S100A6 and neuroblastoma: We speculate that the increased expression of S100A6 following exposure to anticancer drugs demonstrated in our study may indicate a protective role for this protein in neuroblastoma cells and thus suggest this protein as a potential therapeutic target for combined chemotherapy strategies.